Greenwich LifeSciences, Inc.
GLSINasdaqCIK 1799788HealthcareFiscal year ends Dec 31
Reports and events: 70 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2616:30 ET | DEF 14A | Proxy statementPeriod 2026-10-26 | 0001493152-26-048537 |
| 2026-08-1116:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-037147 |
| 2026-06-0418:19 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-027150 |
| 2026-06-0116:56 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-026651 |
| 2025-12-1816:30 ET | 8-K | 5.07 Shareholder vote results | 0001493152-25-028361 |
| 2025-11-1416:30 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-023539 |
| 2025-11-0317:07 ET | DEF 14A | Proxy statementPeriod 2025-11-03 | 0001493152-25-020623 |
| 2025-08-1416:30 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001641172-25-024066 |
| 2025-07-2416:30 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001641172-25-020843 |
| 2025-05-2016:30 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-011731 |
| 2025-04-1516:30 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-004819 |
| 2024-12-1916:15 ET | 8-K | 5.07 Shareholder vote results | 0001493152-24-050777 |
| 2024-11-1416:30 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-045938 |
| 2024-11-0116:10 ET | DEF 14A | Proxy statementPeriod 2024-11-01 | 0001493152-24-043327 |
| 2024-08-1416:33 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-032278 |
| 2024-06-1706:20 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-24-024035 |
| 2024-05-2016:30 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001493152-24-020710 |
| 2024-04-1516:30 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001493152-24-014625 |
| 2024-02-2016:15 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-24-007223 |
| 2024-02-1416:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-006664 |
| 2023-12-1516:15 ET | 8-K | 5.07 Shareholder vote results | 0001493152-23-045048 |
| 2023-10-2517:38 ET | DEF 14A | Proxy statementPeriod 2023-10-24 | 0001493152-23-038176 |
| 2023-10-1916:15 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001493152-23-037702 |
| 2023-08-2116:05 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001493152-23-029605 |
| 2023-05-2216:10 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001493152-23-018539 |
| 2023-04-1306:05 ET | 8-K | 8.01 Other events | 0001493152-23-012053 |
| 2023-03-3116:16 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001493152-23-010284 |
| 2023-03-1306:05 ET | 8-K | 8.01 Other events | 0001493152-23-007316 |
| 2022-12-0916:15 ET | 8-K | 5.07 Shareholder vote results | 0001493152-22-035047 |
| 2022-11-1416:18 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001493152-22-032057 |
| 2022-10-1917:12 ET | DEF 14A | Proxy statementPeriod 2022-10-19 | 0001493152-22-028917 |
| 2022-08-1517:06 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001493152-22-022956 |
| 2022-07-1209:16 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001493152-22-019051 |
| 2022-07-1206:10 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-22-019038 |
| 2022-07-1117:01 ET | 8-K | 8.01 Other events | 0001493152-22-019022 |
| 2022-06-2417:17 ET | 10-K/A | Annual report, amendedPeriod 2021-12-31 | 0001493152-22-017739 |
| 2022-05-2017:00 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001493152-22-014639 |
| 2022-03-2117:24 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001493152-22-007377 |
| 2021-12-1516:15 ET | 8-K | 5.07 Shareholder vote results | 0001493152-21-031573 |
| 2021-12-1306:04 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-031170 |
| 2021-11-1516:38 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001493152-21-028660 |
| 2021-11-1006:52 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-21-027743 |
| 2021-10-1908:06 ET | DEF 14A | Proxy statementPeriod 2021-10-19 | 0001493152-21-025748 |
| 2021-08-1316:16 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001493152-21-019718 |
| 2021-06-1007:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-013960 |
| 2021-06-0907:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-013862 |
| 2021-05-2016:33 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001493152-21-012362 |
| 2021-04-2007:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-009204 |
| 2021-04-1507:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-008809 |
| 2021-04-1307:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-21-008601 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 26, 2026, 16:53 ET. Listed shows no prices and gives no investment advice.